INM Earnings

INM reported its earnings on 2026-02-11, showcasing a revenue of 0.00 against an estimate of 0.00, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following INM's earnings announcement on 2026-02-11, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, INM's stock price tends to shift by an average of +24.19% in the 10 days leading up to earnings and +0.03% in the 10 days following, providing insight into potential market.

For , analysts estimate INM’s annual revenue to reach , while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates revised Revenue Go Down by -40.54% and EPS estimates No Change by % over the past three months, indicating analyst expectation in the company’s performance.

The correlation between INM's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for were Go Down by -40.54%, while EPS estimates moved No Change by % . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, INM's stock price typically moves by +24.19% in the 10 days before its earnings and +0.03% in the 10 days after. For the upcoming earnings, analysts expect an EPS of and revenue of .

The earnings call revealed a net loss increase, rising expenses, and integration challenges with BayMedica. While there is optimism for future product launches, the lack of clear guidance and need for additional financing are concerning. The Q&A highlighted uncertainties in revenue projections and break-even points, which, combined with competitive pressures, suggest a negative sentiment.